Treatment of arsenic poisoning: An update

Indian Journal of Pharmacology

Volumn 30, Issue 4, 1998, Pages 209-217

  Flora, S J S ^a   Tripathi, Neelima ^a  

^a Div of Pharmacology and Toxicology   (India)

Author keywords

Arsenic poisoning; Chelating agents; DMPS; DMSA

Indexed keywords

ARSENIC; CHELATING AGENT; DIMERCAPROL; SUCCIMER; UNITHIOL;

ABDOMINAL PAIN; CHELATION THERAPY; CLINICAL FEATURE; DRUG EFFICACY; DRUG HYPERSENSITIVITY; DRUG SAFETY; HEADACHE; HUMAN; HYPERTENSION; INTOXICATION; INTRAMUSCULAR DRUG ADMINISTRATION; INTRAPERITONEAL DRUG ADMINISTRATION; NUTRITIONAL SUPPORT; ORAL DRUG ADMINISTRATION; REVIEW; SUBCUTANEOUS DRUG ADMINISTRATION; TACHYCARDIA; TOXICOKINETICS; VOMITING;

EID: 0031711420     PISSN: 02537613     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (99)

1. Roy Chowdhury T, Mandai BK, Samanta G, Basu GK, Choudhury PP, Chanda CR et al. Arsenic in groundwater in six districts of West Bengal. India-the biggest arsenic calamity in the world: the status report upto August 1995. In: Abernathy CO, Calderon RL, Chappel WR, editors. Arsenic exposure and Health effects. Chapter 9, New York: Chapman and Hall, 1997:91-111.
2. Garcia-Vargas GG, Cebrian ME, Health effects of arsenic. In: Chang LW, editor. Toxicology of Metals, New York: CRC Lewis Publication, 1996:423-438.
3. Iffland R. Arsenic In: Seiler D, Hans G, Siegel A, Siegel H. editors. Handbook on metals in clinical and analytical chemistry. New York: Marcel Dekker, Inc., 1994:237-53, .
4. IARC, "International Agency for Research on Cancer Monograph on the Evaluation of the Carcinogenic risk to Humans" Overall evaluation of carcinogenicity. An updating of IARC Monograph, Vol 1-42, Lyon, France: IARC Scientific Publication. 1987:1-29.
5. IARC, "Some metals and metallic compounds: Arsenic and Arsenic compounds" International Agency for Research on Cancer monograph, Vol. 58, Lyon, France. IARC Scientific Publication, 1980:119-38.
6. Arnold W, Arsenic In: Seiler, H.G. Siegel H, editors. Handbook on Toxicity of Inorganic Compounds, New York. Marcel Dekker, 1988:1-79.
7. Forth W, Hentchler D, Rummel W, Starke K, editors. Pharmakologie and Toxikologie, Mannheim, Germany, Wissenschaft Verlag, 1992:1-777.
8. Ellenhorn MJ, editor. Metals and Related Compounds, In: Ellenhorn's Medical Toxicology, Diagnosis and Treatment of Human Poisoning, Chap. 67. IInd edition, New York. Williams and Wilkins. 1997:1532-80.
9. Chen CJ, Lai H, Hsu M, Dose response relationship between ingested inorganic arsenic and diabetes mellitus, 4th Annu. Meeting Int. Soc. Environ. Epidemiology, Cuernavaca, Moreloo, Abst, 1992.
10. Ishinishi N, Tsuchiya K, Vahter M, Fowler BA. Arsenic. In: Frieberg L, Nordberg G F, Vonk V, editors. Handbook on the Toxicology of Metals. 2nd Ed, Amsterdam, Elsevier Science Publication B V. 1986:1-43.
11. Pershagen G. The epidemiology of human arsenic exposure. In: Fowler BA, editor. Biological and Environmental effects of arsenic, Amsterdam. Elsevier Science Publication, BV. 1983:199-230.
12. Squibb KS, Fowler BA, editors. The toxicity of arsenic and its compounds, In : Biological and Environmental Effects of arsenic, Amsterdam. Elsevier Science Publication BV, 1983: 232-69.
13. Flora SJS, Das Gupta S. Toxicology of gallium arsenide : An Appraisal. Def Sci J 1994;44:5-10.
14. Flora SJS, Das Gupta S. Effect of single gallium arsenide exposure on some biochemical variables in porphyrin metabolism in rat J Appl Toxicol 1992;12:333-34
15. Webb DR, Sipes IG , Carter DE. In vitro solubility and in vivo toxicity of gallium arsenide. Toxicol Appl Pharmacol 1984;82:405-16.
16. Yamamuchi HC, Takahashi I, Masluki M, Yamamura Y. Biological monitoring of arsenic exposure of gallium arsenide and inorganic arsenic exposed workers by determination of inorganic arsenic and its metabolite in urine and hair. Am Ind Hyg Assoc 1989;50:606-12.
17. Flora SJS, Dube SN, Pant SC, Sachan AS, Effect of multiple gallium arsenide exposure on some biochemical alterations in rat brain. Indust Health 1994;32:239-44.
18. Tsalev DL, Zaprianov ZK, editors. Atomic absorption spectrometry in occupational and environmental health practice, Vol. 1, Boca Raton, USA, CRC Press, 1983:87.
19. Kabata-Pendias A, Pendias H, editors. Trace elements in soil and plants, Vol. 6, Boca Raton, USA, CRC Press, 1985: 171.
20. Environmental Protection Agency (EPA) USA. Lead arsenate. In: International memorandum by JS Dollarhide, Cincinnati, OH. EPA Press, Environmental Criteria and Assessment Office, 1994.
21. Kloke A, In: Behrens, D and Wiesner J, editors. Assessment of Heavy metal concentration in soils. Frankfurt, Germany, Bechema Press, 1988, p 77.
22. Kraus RJ, Ganther HE. Synergistic toxicity of arsenic and methylated selenium compounds. Biol Trace Elem Res 1989;20: 105-13.
23. Schmoke G, Elsonhans B, Ehtechami C. Forth W. Arsenic copper interaction in the kidney of the rat. Human Exp Toxicol 1992;11: 315-21.
24. 3H/St mice. Bioinorg Chem 1978;9:245-47.
25. Mahaffey KR, Capar SG., Gladen BC, Fowler BA. Concurrent exposure to lead, cadmium and arsenic. Effect on toxicity and tissue metal concentration in the rat. J Lab Clin Med 981;98:463-81.
26. Tamamura S. Influence of dietary milk in heavy metal toxicity. Folia Pharmacol Jpn 1972;68:586-601.
27. Flora SJS, Pant SC, Malhotra PR, Kannan GM. Biochemical and histopathological changes in arsenic intoxicated rats coexposed to ethanol. Alcohol 1997;14:563-68.
28. Aposhian HV, Maiorino RM, Gorizalez Ramirez DG, Zunigacharles M, Xu Z, Hurlbut M, Junco-Manoz P et. al., Mobilization of heavy metals by newer therapeutically useful chelating agents. Toxicology 1995;97:23-38.
29. Angle CR. Organ-specific therapeutic intervention. In: Goyer RA, Klaassen CD, Waalkes MR editors. Metal Toxicology, New York: Academic Press, Inc. 1995:71-110.
30. Hoover TD, Aposhian H.V. BAL increases the Arsenic - 74 content of rabbit Brain. Toxicol Appl Pharmacol 1983;70: 160-62.
31. Aposhian HV, Carter DE, Hoover TD, Hsu CA, Maiorino RM, Stine E. DMSA, DMPS and DMPA as arsenic antidotes. Fund Appl Toxicol 1984;4:S58 - S70.
32. Klaassen CD. Heavy metals and Heavy metal antagonists. In: Hardman JG, Limbird LE, Molinoff PB, Ruddon RW, Gilman AG, editors. Goodman and Gilman's The Pharmacological basis of Therapeutics. 9th edition, New York, McGraw-Hill, 1996;1605-27.
33. Angle CR. Childhood lead poisoning and its treatment. Annu Rev Pharmacol Toxicol 1993;32:409-34.
34. Aposhian HV, Aposhian MM. Meso 2,3-dimercaptosuccinic acid: chemical, pharmacological and Toxicological properties of an orally effective metal chelating agent. Annu Rev Pharmacol Toxicol 1990;30:279-306.
35. Lenz K, Hruby K, Bruml W, Elder A, Gaszner A at al. 2,3-dimercaptosuccinic acid in human arsenic poisoning. Arch Toxicol 1981;47:241-43.
36. Tadlock CH, Aposhian HV, Protection of mice against the lethal effects of sodium arsenite by 2,3-dimercapto-1-propane-sulfonic acid and 2,3- dimercaptosuccinic acid. Biochem Biophy Res Commun 1980;94:501-7.
37. Aposhian HV, Tadlock CH, Moon TE, Protected of mice against lethal effects of sodium arsenite-a quantitative comparison of a number of chelating agents. Toxicol Appl Pharmacol 1981;51:385-92.
38. Okonishnikova IE, Experimental therapy and prophylaxis of acute poisoning with arsenic compounds. Gig Tr Prof Zabol 1965;9:38-43.
39. Graziano JH, Cuccia D, Friedheim E. The pharmacolgy of 2,3-dimercaptosuccinic acid and its potential use in arsenic poisoning. J Pharmacol Exp Ther 1979;207:1051-55.
40. Shum S, Whitehead J. Vet. Hum. Toxicol., 1994; 36: 341, as seen in Angle CR. Chelation therapies for metal intoxication. Chap. 31. In Toxicology of Metals, Boca Raton. CRC Press, 1996:487-504.
41. Shum S, Whitehead J. Vet. Hum. Toxicol., 1994; 36: 341, as seen in Angle CR. Chelation therapies for metal intoxication. Chap. 31. In Toxicology of Metals, Boca Raton. CRC Press, 1996:487-504.
42. Aposhian HV. DMSA and DMPS water soluble antidotes for heavy metal poisoning. Annu Rev Pharmacol Toxicol 1983;23:193-215.
43. Reynolds JEF, editor. Martindale: The Extra Pharmacopei (electronic version), Denver, CO: Micromedex Inc., 1994.
44. Ding GS, Liang YY. Antidotal effects of Dimercapto-succinic acid. J Appl Toxicol 1991;11:7-14.
45. Flora SJS, Dube SN, Arora U, Kannan GM, Shukla MK, Malhotra PR. Therapeutic potential of meso 2,3-dimercaptosuccinic acid or 2,3-dimercaptopropane 1-sulfonate in chronic arsenic intoxication in rats. Biometals 1993;8:114-16.
46. Tripathi N, Flora SJS. Effect of some thiol chelators on enzymatic activities in Blood, liver and kidneys of acute arsenic (III) exposed mice. Biomed Environ Sci 1998;11:38-45.
47. Pershagen G. Lung cancer mortality among men living near arsenic emitting smelters. Amer J Epidemiol 1985;122: 684-94.
48. Tallis GA. Acute lead arsenate poisoning. Aust NZ J Med 1989;19:730-32.
49. Berlin M, Jerksell LG, Nordberg G. Accelerated uptake of mercury by brain caused by 2,3-dimercaptopropanol (BAL) after injection into the mouse of methylmercury compounds. Acta Pharmacol Toxicol 1965; 23:312-20.
50. Tripathi N, Kannan GM, Pant BP, Jaiswal DK, Malhotra PR, Flora SJS. Arsenic-induced changes in certain neurotransmitter levels and their recoveries following chelation in rat whole brain.Toxicol Letters, 1997;92:201-08.
51. Aposhian HV, Tadlock CH, Moon TE. Protection of mice against the lethal effects of sodium arsenite- A quantitative comparison of a number of chelating agents. Toxicol Appl Pharmacol 1981;61:385-92.
52. Domingo JL, Bosque MA, Piera V, Meso 2,3-dimercaptosuccinic acid and prevention of arsenite embryotoxicity and teratogenicity in the mouse. Fund Appl Toxicol 1991;17:314-20.
53. Domingo JL, Bosque MA, Llobet JM, Corbella J. Amelioration by BAL (2,3-dimercapto-1-propanol) and DMPS (sodium 2,3-dimercapto-1-propanesulfonic acid) of arsenite developmental toxicity in mice. Ecotoxicol Environ Safety 1992;23:274-81.
54. Grandjean P, Jacobsen IA, Jorgensen PJ. Chronic lead poisoning treated with dimercaptosuccinic acid. Pharmacol Toxicol 1991;68:266-69.
55. Angle CR. Chelation therapies for metal intoxication, In: Chang LW, editor. Toxicology of Metals, Boca Raton, FL, USA: CRC Press. 1996; 487-504.
56. Kreppel H, Paepcke U, Thiermann H, Szinicz L, Reichl F.X, Singh P.K., Jones M.M, Therapeutic efficacy of new dimercaptosuccinic acid (DMSA) analogues in acute arsenic trioxide poisoning in mice. Arch Toxicol 1993;67:580-85
57. Petrunkin V.E. Synthesis and properties of dimercapto derivatives of alkylsurfonic acids. UKr Kham Zh 1956;22: 603-07.
58. Hruby K, Donner A. 2,3-dimercapto-1-propanesulphonate in heavy metal poisoning. Med Toxicol 1983;2:317-23.
59. Goebel HH, Schmidt PF, Bohl J, Tettenborn B, Kramer G, Gutman L, Polyneuropathy due to acute arsenic intoxication: biopsy studies. J Neuropathol Exp Neuron 1990;49:137-49.
60. Ashton CE, House I, Volans G. Severe intravenous metallic mercury poisoning successful treatment with long term 2,3-dimercaptoproapne 1-sulfonate (DMPS): European Assoc. of Toxicology and Poison Control Centres Meeting, Istanbul, 1992.
61. Moore DF, O'Callaghan CA, Berlyne G, Ogg CS, Davies, HA, House IM., Henry JA. Acute arsenic poisoning : absence of polyneuropathy after treatment with 2,3-dimercapto propanesulphonate (DMPS). J Neurol Neurosurg Psychiat 1994;54:1133-35.
62. Klimmek R, Krettek C, Werner HW. Acute effects of the heavy metal antidotes DMPS and DMSA on circulation, respiration and blood homeostasis in dogs. Arch Toxicol 1993;67:428-34.
63. Hauber W, Weger N.Treatment of arsenic poisoning in mice with sodium dimercapto-1-sulfonate. In: Boissier JR, editor. VII International Conference of Pharmacology, Paris. Elmsford, New York: Pergamon Press, 1978.
64. 35S-meso dimercaptosuccinic acid (succimer). In: BT Velichkovskii editor. Voprosy Eksp KlinTer Profil Prom Intoksikatsii Sverdkovsk 1974:11-14.
65. Hauser W, Weger N, Treatment of arsenic poisoning in mice with sodium-dimercaptopropane-1-sulfonate. In: Proc Int Congr Pharmacol Paris (Abstr.). 1989.
66. Forth W, Hnschler D, Rummel W, Starke K, editors. In: Allgemeine und spezielle pharmakologic und toxikologe Vol. 6, Manheim, Germany, Wissenschafts Verlag. 1992:1-768.
67. Catsch A, Harmuth-Hoene HA. Pharmcology and therapeutic applications of agents used in heavy metal poisoning. Pharmacol Ther 1976; A1:1-118.
68. Wildenauer DB, Reuther H, Weger N. Interactions of the chelating agent 2,3-dimercapto propane-1-sulfonate with red blood cells in vitro. I. Evidence for carrier mediated transport Chem Biol Interact 1982;42:165-77.
69. Planas-Bohne F. The influence of chelating agents on the distribution and biotransformation of methylmercuric chloride in rats. J Pharmacol Exp Ther 1981;217:500-4.
70. Tadlock CH, Aposhian HV. Protection of mice against the lethal effects of sodium arsenite by 2,3-dimercapto-1-propane-sulfonic acid and dimercaptosuecinic acid. Biochem Biophys Res Commun 1980; 94:501-7.70. Kreppel H, Reichl F.X, Szinicz L, Fichtl B, Forth W, Efficacy of various dithiol compounds in acute arsenic poisoning in mice. Arch Toxicol 1990;64:387-92.
71. Tadlock CH, Aposhian HV. Protection of mice against the lethal effects of sodium arsenite by 2,3-dimercapto-1-propane-sulfonic acid and dimercaptosuecinic acid. Biochem Biophys Res Commun 1980; 94:501-7.70. Kreppel H, Reichl F.X, Szinicz L, Fichtl B, Forth W, Efficacy of various dithiol compounds in acute arsenic poisoning in mice. Arch Toxicol 1990;64:387-92.
72. Kreppel H, Reichl F.X. Szinicz L, Fichtl B, Forth W. Efficacy of various dithiol compounds in acute arsenic poisoning in mice. Arch Toxicol 1990;64:387-92.
73. Kreppel H, Paepeke, U, Thiermann H, Szinicz L, Reichi FX, Singh PK, Jones, MM, Therapeutic efficacy of new dimercaptosuccinic acid (DMSA) analogues in acute arsenic trioxide poisoning. Arch Toxicol 1993;67:580-85.
74. Kreppel H, Knebel R, Reichi FX, Ficht B, Mueckter H, Forth W. Influence of dithiol compound and the newly synthesized compounds bis (acethylthio) propanesulfonamide on tissue contents and elimination of arsenic in mice. In: Anke M, Bauman W, Braulich H, Brukner C, Groppel B, Grun M, Editors. Proc. Sixth Trace Elements Symposium As, B, Br, Co, Cr, F, Fe, Mn, Ni, Sb, Sc, Si, Sn, and other Ultra Trace Elements, Vol. 4, Jena, FRG, 1989:1046-52.
75. Kreppel H, Reichi FX, Mueckter H, Ficht B, Forth W. Influence of oral tretament with dithiol compounds on the survival rate of mice poisoned with arsenic In: Anke M, Bauman W, Braulich H, Brukner C, Groppel B, Grun M editors. Proc. Sixth Trace Elements Symposium, As, B, Br, Co, Cr, F, Fe, Mn, Ni, Sb, Sc, Si, Sn, and other Ultra Trace Elements, Vol. 4, Jena, FRG, 1989:1039-45.
76. Jones MM, Singh PK, Gale GR, Atkins LM, Smidth AB. Esters of meso-dimercaptosuccinic acid as cadmium mobilizing agents. Taxicol Appl Pharmacol 1988;95:507-14.
77. Singh PK, Jones MM, Xu ZF, Gale GR, Smith AB. Atkins A.B. Mobilization of lead by esters of meso 2, dimercaptosuccinic acid. J Toxicol Environ Health 1989;27:423-34.
78. Jones MM. New Developments in therapeutic chelating agents as antidotes for metal poisoning. Crit Rev Toxicol 1991;21:209-32.
79. Kreppel H, Reichl FX, Andreas K, Szinicz L, Singh PK, Jones MM. Antidotal efficacy of Newly synthesized Dimercaptosuccinic acid (DMSA), Monoesters in Experimental Arsenic poisoning in mice. Fund Appl Toxicol 1995;26: 239-45.
80. Klaassen CD. Heavy metals and heavy metal antagonists. In: Hardman JG, Limbird LE, Molinoff PB, Ruddon RW, Gilman AG, editors. Goodman and Gilman's The Pharma-cological basis of therapeutics. New York. McGraw-Hill, 1990:1592-1614.
81. Flora SJS, Dube SN. Chelating agents for the treatment of lead intoxication: An appraisal. Indian J Environ Toxicol 1995;5: 1-6.
82. Flora SJS, Mathur S, Mathur R. Effects of meso 2,3-dimercaptosuccinic acid or 2,3- dimercaptopropane 1- sulfonate on beryllium induced biochemical alterations and metal concentration in male rats. Toxicology 1995;95: 167-75.
83. Kemper FH, Jekat FW, Bertram HP, Eckard R. New chelating agents. In: G.N. Volans, GN, Smith J, Sullivan FM, Tumer P. editors. Basic Science in Toxicology. Brighton, UK. Taylor & Francis, 1990.
84. Flora SJS, Kumar P. Biochemical and immunotoxicological evaluation of metal chelating drugs in rats. Drug Invest 1993;5: 269-73.
85. Flora SJS, Pant SC, Sachan AS. Mobilization and distribution of lead over the course of combined treatment with thiamine and meso 2,3-dimercaptosuccinic acid or 2,3-dimercaptopropane sulphonate in rats. Clin Chem Enzym Comms 1994;6: 207-16.
86. Flora GJS, Seth PK, Kannan GM, Pant BR Malhotra PR. Combined therapeutic efficacy of few thiols with calcium disodium versenate during acute lead intoxication in mice. Trace Elem Electr 1996;13: 33-6.
87. Tandon SK, Singh S, Flora SJS. Influence of methionine and zinc supplementation during chelation of lead in rats. J Trace Elem Electro Health Diseases 1994;8:75-7.
88. Flora SJS, Tandon SK. Preventive and therapeutic effects of thiamine, ascorbic acid and their combination in lead intoxication. Acta Pharma et Toxicol 1986;58: 374-8.
89. Dhawan M, Flora SJS, Tandon SK. Preventive and therapeutic role of Vit.E in chronic plumbism. Biomed Environ Sci 1989;2: 335-40.
90. Environmental Protection Agency (EPA). Special report on ingested inorganic arsenic, skin cancer, nutritional essentiality. Washington: EPA Press. EPA Publication no. EPA/625/ 3-87/013, 1988.
91. Harding BI, Arsenic. In: Lederer WH, Fensterheim RJ, editors, Industrial, Biomedical and Environmental Perspectives, New York: Van Nostrand Reinhold, 1983: 203-09.
92. Flora SJS, Tandon SK. Adjuvants for therpeutic chelating drugs in lead intoxication. Trace Elem Electro 1995;12: 131-40.
93. Flora SJS, Bhattacharya R, Vijayaraghavan R. Combined therapeutic potential of meso 2,3-dimercaptosuccinic acid and calcium disodium edetate on the mobilization and distribution of lead in experimental lead intoxication in rats. Fund Appl Toxicol 1995; 25: 233-40.
94. Flora SJS, Dube SN, Vijayaraghavan R, Pant SC. Changes in certain hematological and physiological variables following single gallium arsenide exposure in rats. BiolTrace Elem Res 1997;58:197-208.
95. Sikorski EE, McCay JA White KL et al. Immunotoxicity of the semiconductor gallium arsenide infernale B6C3F1 mice. Fund Appl Toxicol 1989;13: 843-58.
96. Flora SJS, Kumar P, Kannan GM, Rai GP. Acute gallium arsenide exposure and changes in certain haematological, hepatic, renal and immunological indices at different time interval in male wistar rats. Toxicol Letters 1997: (in press)
97. Flora SJS, Kumar P. Biochemical and immunotoxiclogical alterations following repeated gallium arsenide exposure and their recoveries by meso 2,3- dimercaptosuccinic acid and 2,3- dimercaptopropane 1-sulfonate administration in rats. Environ Pharmacol Toxicol 1996;2: 315-20.
98. Burns LA, Butterworth LF, Munson AE. Reversal of gallium arsenide induced suppression of the antibody response by a mixed disulfide metabolite of meso 2,3- dimercaptosuccinic acid. J Pharmacol Exp Ther 1993;264: 695-700.
99. Muckter H, Liebl B, Reichl F-X, Hunder G, Walther U, Fichtl B. Are we ready to replace dimercaprol (BAL) as an arsenic antidote ? Human Exp Toxicol 1997;16: 460-65.